I would appreciate that, since we are studying this issue. We would like to know about more effective approaches to ensure drug safety, both before and after they are put on the market.
If the approval process is shortened in order to get a drug to market, there may be impacts, and we will have to react after the fact. That might mean that people will die or suffer irreversible health consequences, such as blood clots, aneurysms or other serious effects.
Could shortening the approval process have a direct impact on people's health?